PMC:7283670 / 42275-42416
Annnotations
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T134 | 83-91 | Body_part | denotes | capsules | http://purl.org/sig/ont/fma/fma85272 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T401 | 11-12 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T100 | 28-37 | Chemical | denotes | Lopinavir | http://purl.obolibrary.org/obo/CHEBI_31781 |
| T101 | 105-119 | Chemical | denotes | glucocorticoid | http://purl.obolibrary.org/obo/CHEBI_24261 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T431 | 0-16 | Sentence | denotes | Interferon a‐1b: |
| T432 | 17-48 | Sentence | denotes | 51 (100%), Lopinavir/Ritonavir: |
| T433 | 49-92 | Sentence | denotes | 51 [100%], Bacillus licheniformis capsules: |
| T434 | 93-130 | Sentence | denotes | 44 [86.3%], glucocorticoid treatment: |
| T435 | 131-141 | Sentence | denotes | 10 (19.6%) |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 1152 | 60-82 | Species | denotes | Bacillus licheniformis | Tax:1402 |
| 1213 | 28-47 | Chemical | denotes | Lopinavir/Ritonavir | MESH:C558899 |